Literature DB >> 15256069

Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation.

M Ebadi1, S K Sharma, S Wanpen, A Amornpan.   

Abstract

We have used control-homozygous weaver mutant, and -heterozygous weaver mutant mice in order to explore the basic molecular mechanism of neurodegeneration and the neuroprotective potential of coenzyme Q(10). Homozygous weaver mutant mice exhibited progressive neurodegeneration in the hippocampus, striatum, and cerebellum, and a reduction in the striatal levels of dopamine and coenzyme Qs (Q(9) and Q(10)) without any significant changes in norepinephrine and serotonin. Mitochondrial complex-1 was down regulated; whereas nuclear factor-kappa B was up regulated in homozygous weaver mutant mice. Rotenone inhibited complex-1, enhanced nuclear factor-kappa B, and caused apoptosis in human dopaminergic (SK-N-SH) neurons; whereas nuclear factor-kappa B antibody suppressed rotenone-induced apoptosis, suggesting that enhancing coenzyme Q(10) synthesis and suppressing the induction of NF-kappa B, may provide neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256069      PMCID: PMC6740220          DOI: 10.1111/j.1582-4934.2004.tb00276.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  15 in total

1.  Nitric oxide, glial cells and neuronal degeneration in parkinsonism.

Authors:  E C Hirsch; S Hunot
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

2.  Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.

Authors:  S O McGuire; Z D Ling; J W Lipton; C E Sortwell; T J Collier; P M Carvey
Journal:  Exp Neurol       Date:  2001-06       Impact factor: 5.330

Review 3.  Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.

Authors:  M Ebadi; P Govitrapong; S Sharma; D Muralikrishnan; S Shavali; L Pellett; R Schafer; C Albano; J Eken
Journal:  Biol Signals Recept       Date:  2001 May-Aug

4.  Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype.

Authors:  Jun Peng; Zhijin Wu; Yongqin Wu; Mike Hsu; Fang Feng Stevenson; Rapee Boonplueang; Suzanne K Roffler-Tarlov; Julie K Andersen
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

5.  The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: characterization of the effect on midbrain dopaminergic neuron survival.

Authors:  M Blum; C Weickert; E Carrasco
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

6.  Neurons exhibiting dopamine D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse.

Authors:  S G Xu; C Prasad; D E Smith
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

7.  Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.

Authors:  R Krüger; C Hardt; F Tschentscher; S Jäckel; W Kuhn; T Müller; J Werner; D Woitalla; D Berg; N Kühnl; G A Fuchs; E J Santos; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

8.  Peroxynitrite formed by mitochondrial NO synthase promotes mitochondrial Ca2+ release.

Authors:  U Bringold; P Ghafourifar; C Richter
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

9.  Mutation analysis and association studies of nuclear factor-kappaB1 in sporadic Parkinson's disease patients.

Authors:  P Wintermeyer; O Riess; L Schöls; H Przuntek; B Miterski; J T Epplen; R Krüger
Journal:  J Neural Transm (Vienna)       Date:  2002-09       Impact factor: 3.575

10.  A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation.

Authors:  Deborah J Clarke; Richard L Branton
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

View more
  12 in total

1.  Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.

Authors:  Sirirat Klongpanichapak; Piyarat Govitrapong; Sushil K Sharma; Manuchair Ebadi
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

Review 2.  Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Authors:  Manuchair Ebadi; Holly Brown-Borg; Hesham El Refaey; Brij B Singh; Scott Garrett; Shaik Shavali; Sushil K Sharma
Journal:  Brain Res Mol Brain Res       Date:  2005-03-24

3.  Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.

Authors:  Patcharee Kooncumchoo; Sushil Sharma; James Porter; Piyarat Govitrapong; Manuchir Ebadi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training.

Authors:  Ragip Pala; Cemal Orhan; Mehmet Tuzcu; Nurhan Sahin; Shakir Ali; Vedat Cinar; Mustafa Atalay; Kazim Sahin
Journal:  J Sports Sci Med       Date:  2016-02-23       Impact factor: 2.988

5.  Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis.

Authors:  Farzad Salehpour; Fereshteh Farajdokht; Paolo Cassano; Saeed Sadigh-Eteghad; Marjan Erfani; Michael R Hamblin; Maryam Moghadam Salimi; Pouran Karimi; Seyed Hossein Rasta; Javad Mahmoudi
Journal:  Brain Res Bull       Date:  2018-10-29       Impact factor: 4.077

6.  The promise of neuroprotective agents in Parkinson's disease.

Authors:  Stacey E Seidl; Judith A Potashkin
Journal:  Front Neurol       Date:  2011-11-21       Impact factor: 4.003

Review 7.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

Review 8.  Coenzyme Q10: Novel Formulations and Medical Trends.

Authors:  Carmen J Pastor-Maldonado; Juan M Suárez-Rivero; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Manuel Munuera-Cabeza; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; José A Sánchez-Alcázar
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 9.  Preventing Myocardial Injury Following Non-Cardiac Surgery: A Potential Role for Preoperative Antioxidant Therapy with Ubiquinone.

Authors:  Qun Chen; Steven Qi; Laura Hocum-Stone; Edward Lesnefsky; Rosemary F Kelly; Edward O McFalls
Journal:  Antioxidants (Basel)       Date:  2021-02-10

10.  Regulation of pentraxin-3 by antioxidants.

Authors:  A L Hill; D A Lowes; N R Webster; C C Sheth; N A R Gow; H F Galley
Journal:  Br J Anaesth       Date:  2009-10-28       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.